Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

Barbour, 1989, Arachidonic acid produces a prolonged inhibition of glutamate uptake into glial cells, Nature, 342, 918, 10.1038/342918a0 Carlson, 1986, High fat diets varying in ratios of polyunsatured to saturated fatty acid and linoleic to linoleic acid: A comparison of rat neural and red cell membrane phospholipids, Journal of Nutrition, 116, 718, 10.1093/jn/116.5.718 Connor, 1993, Is the docosahexanoic acid (DHA) content of erythrocytes a marker for the DHA content of brain phospholipids?, FASEB Journal, 7, A152 Davidson, 1988, Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices, European Journal of Pharmacology, 149, 317, 10.1016/0014-2999(88)90662-0 Davidson, 1994, Exogenous polyenoic fatty acids modulation of dopaminergic neurotransmission in cat and rat (Abstract), Neuropsychopharmacology, 10, 17S Gattaz, 1990, Increased serum phospholipase A2 activity in schizophrenia: A replication study, Biological Psychiatry, 28, 495 Gattaz, 1994, Accelerated breakdown of platelet membrane phospholipids in schizophrenia (Abstract), Schizophrenia Research, 11, 122 Glen, 1994, A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases, Schizophrenia Research, 12, 53, 10.1016/0920-9964(94)90084-1 Koletzko, 1992, Fats for brains, European Journal of Clinical Nutrition, 46, 551 Kovaleva, 1989, Lipid peroxidation processes in patients with schizophrenia, Zhurnal Neuropatologii i Psikhiatrii, 89, 108 Manku, 1982, Fatty acids in plasma and red cell membranes, Lipids, 18, 906, 10.1007/BF02534572 Maras, 1994, Increased platelet phospholipase A2 activity in schizophrenics and reduction after neuroleptic treatment (Abstract), Schizophrenia Research, 11, 123 Maziere, 1988, Trifluoperazine increases fatty acid turnover in phospholipids in cultured human fibroblasts, Lipids, 23, 419, 10.1007/BF02535513 Mellor, 1994, Eicosapentanoic acid and schizophrenia (Abstract), Neuropsychopharmacology, 10, 256S Moore, 1991, Astrocytes, not neurons, produce docosahexanoic acid and arachidonic acid, Journal of Neurochemistry, 56, 518, 10.1111/j.1471-4159.1991.tb08180.x Peet, 1994, Arachidonic acid: A common link in the biology of schizophrenia?, Archives of General Psychiatry, 51, 665, 10.1001/archpsyc.1994.03950080077012 Peet, 1993, Tardive dyskinesia, lipid peroxidation and sustained amelioration with vitamin E treatment, International Clinical Psychopharmacology, 8, 151, 10.1097/00004850-199300830-00003 Pettegrew, 1991, Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first episode drug-naive schizophrenics, Archives of General Psychiatry, 48, 563, 10.1001/archpsyc.1991.01810300075011 Phillips, 1993, Increased pentane and carbon disulphide in the breath of patients with schizophrenia, Journal of Clinical Pathology, 46, 861, 10.1136/jcp.46.9.861 Piomelli, 1991, Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism, Nature, 353, 164, 10.1038/353164a0 Satoh, 1978, Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method, Clinica Chimica Acta, 90, 37, 10.1016/0009-8981(78)90081-5